ID CLB HC.PH.BIO.CLB
Develops drugs, biologics or cell and gene therapies with no approved product on the market (no revenue, or milestones only); such a developer is here, not in contract research.
Sector, group and industry above this class, as placed in the current release. The sector and the industry link to their companies.
Companies whose primary class this is. The sector and industry pages and the screener count them the same way.
| Company | Ticker | Country | Market cap | Filings |
|---|---|---|---|---|
| Pharos iBio Co., Ltd. | 388870 | South Korea | — | 116 |
| Sirtris Pharmaceuticals, Inc. Delisted | — | United States of America | — | 116 |
| Viragen International Inc Delisted | VGNI | United States of America | — | 115 |
| Avantogen Oncology, Inc. Delisted | — | United States of America | — | 114 |
| AXYS PHARMACEUTICALS INC Delisted | — | United States of America | — | 113 |
| HanchorBio Inc. | 7827 | Taiwan | — | 113 |
| CepTor CORP Delisted | — | United States of America | — | 112 |
| Turnstone Biologics Corp. Delisted | — | United States of America | — | 112 |
| Cantabio Pharmaceuticals Inc. Delisted | — | United States of America | — | 110 |
| Nexell Therapeutics Inc Delisted | NEXL | United States of America | — | 110 |
| ME Therapeutics Holdings Inc. | METX | Canada | — | 108 |
| Achilles Therapeutics plc Delisted | ACHL_old | United States of America | — | 107 |
| CURAXIS PHARMACEUTICAL Corp Delisted | — | United States of America | — | 107 |
| EPIGEN INC Delisted | — | United States of America | — | 106 |
| Virexx Medical Corp Delisted | REX1 | United States of America | — | 106 |
| Aladdin Healthcare Technologies SE | NMI | Germany | — | 105 |
| 4D Pharma PLC Delisted | DDDD | United Kingdom | — | 103 |
| Acepodia, Inc. | 6976 | Taiwan | — | 103 |
| Incanthera plc | INC | United Kingdom | — | 103 |
| Steminent Biotherapeutics Inc. | 7729 | Taiwan | — | 103 |
| VISEN Pharmaceuticals | 2561 | Cayman Islands | — | 103 |
| Applied Molecular Evolution Inc Delisted | AMEV | United States of America | — | 102 |
| Duality Biotherapeutics, Inc. | 9606 | Cayman Islands | — | 102 |
| MATRIX PHARMACEUTICAL INC Delisted | — | United States of America | — | 102 |
| NOVADIGM INC Delisted | — | United States of America | — | 102 |
| Noile-Immune Biotech Inc. | 4893 | Japan | — | 101 |
| Sunho Biologics, Inc. | 2898 | Hong Kong | — | 101 |
| Atrium Therapeutics, Inc. | RNA | United States of America | — | 100 |
| Cloudbreak Pharma Inc. | 2592 | Hong Kong | — | 100 |
| RayzeBio, Inc. Delisted | RYZB | United States of America | — | 100 |
| Clementia Pharmaceuticals Inc Delisted | CMTA | United States of America | — | 99 |
| XOMA LTD Delisted | — | United States of America | — | 98 |
| NEXUS BIOPHARMA INC Delisted | — | United States of America | — | 97 |
| Oncodesign Precision Medicine S.A | ALOPM | France | — | 97 |
| DELTAGEN INC Delisted | — | United States of America | — | 96 |
| InNexus Biotechnology Inc. Delisted | IXSBF | Canada | — | 96 |
| Kedem Pharmaceuticals Inc. Delisted | — | United States of America | — | 96 |
| Applied BioSciences Corp. Delisted | — | United States of America | — | 95 |
| GenFleet Therapeutics (Shanghai) Inc. | 2595 | Hong Kong | — | 95 |
| CELTRIX PHARMACEUTICALS INC Delisted | — | United States of America | — | 94 |
| Gpc Biotech Ag Delisted | GPCBY | United States of America | — | 94 |
| Medisun Precision Medicine Ltd. Delisted | — | United States of America | — | 94 |
| Avant Technologies Inc. | — | United States of America | — | 93 |
| Vicapsys Life Sciences, Inc. Delisted | — | United States of America | — | 92 |
| TETRAGENEX PHARMACEUTICALS, INC. Delisted | — | United States of America | — | 89 |
| InSilico Medicine Cayman TopCo | 3696 | Cayman Islands | — | 88 |
| Serodus ASA Delisted | SER | Norway | — | 88 |
| SUNOVION CNS DEVELOPMENT CANADA ULC Delisted | — | United States of America | — | 88 |
| IntoCell, Inc. | 287840 | South Korea | — | 86 |
| Veradermics, Inc | MANE | United States of America | — | 86 |
Other names for this activity, and where neighboring activities go instead.
preclinicaldrug developer
Research-led company whose approved medicines, which it discovered, are in one or two therapeutic areas; it moves to Branded Prescription Drugs only after two consecutive annual reports with approved products in three or more.
https://financialfilings.com/oics/CLB/
This page is keyed by the class ID CLB. IDs are assigned in v0.3 and freeze at v1.0; from then on an ID is never renamed or reused, and if the class moves in the tree, its ID and this URL stay the same.
Sign in or create a free account - no password needed.
By continuing, you agree to our Terms and Privacy Policy.